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There is an old tale of three blind men who were brought to
the zoo for the ﬁrst time and allowed to touch the elephant.
On their way home, they shared this exciting experience. “An
elephant is a long, ﬂexible, and cylindrical creature,” said the
man who had touched the elephant’s trunk. “No! It is a thin
and ﬂat creature,” said the man who had touched the ele-
phant’s ear. “No, no! An elephant is rough and rigid like a
tree stem,” disagreed the third person who had touched the
elephant’s leg. And the truth is that all three men were right!
When trying to see the invisible with our medical imag-
ing systems, we are much like those three blind men. With
each imaging modality, we shed some light on a diﬀerent as-
pect of the general physiological picture. Although in some
cases one modality may suﬃce to provide a deﬁnitive clinical
answer, this is not the case in many other situations. Multi-
modal imaging (MMI) is needed for three basic reasons: (a)
to acquire complementary information which may be needed
to reach a deﬁnitive diagnostic conclusion, exclude certain
pathologies, or obtain quantitative values (e.g., [1, 2]); (b) to
create synergism by data fusion (i.e., to provide added infor-
mationandnewimageswhicharemoreinformativethanthe
individual source images); (c) to plan therapeutic procedures
and monitor treatment (e.g., [3, 4]).
An ideal MMI system or method should be capable of
performing all three tasks mentioned above. Naturally, that
requirement might be too demanding in terms of technolog-
ical capabilities and operational considerations. Hence, di-
agnostic and therapeutic systems are commonly separated.
However, one may see in the near future more system inte-
gration in the form of image-guided therapy.
There are several technical issues that are associated with
M M I .Ap r e r e q u i s i t ei st oo b t a i ne ﬀective fusion and display
of the data (e.g., [5–7]). Accurate spatial (and maybe also
temporal)alignmentiscrucialforeﬀectivedatafusion.There
are basically two approaches for achieving coregistration.
The ﬁrst, which may be called the “hardware” approach,
utilizes a hybrid design comprising two (or more) imaging
modalities that are contained within a single device. The
advantage of this approach is that the imaging modalities
acquire data sequentially while the patient lies on the bed.
The disadvantage is the need for dedicated MMI equipment
which may be cumbersome or costly.
The second approach for achieving coregistration is
the “software-” based approach. With this approach, image
properties and tissue geometry and texture are used as clues
for aligning the data sets. Alignment is thus achieved by ma-
nipulatingtheacquireddataundercertainoptimizationcon-
straints or 3D model to achieve the best (most probable)
match (e.g., [8–11]). Of course this approach is susceptible
to noise and artifacts, but on the other hand it allows bet-
ter versatility, and in many cases may be applied success-
fully to scans performed on diﬀerent occasions and at dif-
ferent locations. Nevertheless, it is now widely recognized
that the merger of information is more eﬃciently achieved
by the hardware approach. The recent (2001) introduction
of hybrid scanners has led to an expansion of this approach
through the rapid adoption of the technology into the clini-
cal arena.
One of the most promising examples of MMI hybrid sys-
temsthatiscurrentlydemonstratingasigniﬁcantclinicalim-
pact is the combination of CT with nuclear imaging, and
speciﬁcally positron emission tomography (PET). Following
the development of a prototype in the late 1990s [12], the
ﬁrst commercial combined PET/CT scanner was introduced
in 2001 and since then, close to 2000 of such devices from
diﬀerent vendors have been installed in clinics worldwide.
Both CT and PET technologies continue to advance and
since 2006, new PET scanners are now only available in com-
bination with CT. The MMI technology available clinically
has demonstrated particular impact in staging malignant2 International Journal of Biomedical Imaging
disease [13, 14] and in monitoring response of the disease
to therapy. The recent incorporation of high-speed, multi-
slice CT scanners with PET also opens up the potential for
applying this technology to cardiac disease.
Another attractive modality for MMI is MRI. Although
MRI imposes severe restrictions on the imaging environ-
ment, it oﬀe r sab r o a ds p e c t r u mo fs c a nt y p e sa n di m -
age contrast. Compared with CT, MRI oﬀers greater soft-
tissue contrast, better capability for quantitation of func-
tion (e.g., measurement of blood ﬂow or tissue metabolism),
and potentially new types of molecularly targeted contrast
agents. Eﬀorts for combining MRI with other modalities
(e.g., PET/MRI and ultrasound/MRI) are currently under
development.
Another aspect of MMI is the development of multi-
modal contrast enhancing materials. Such materials can be
used in the form of a “ﬁt-all” type of marker (e.g., [15]).
Thus,theirsignalscanbeusedascontrolpointsfor3Dalign-
ment. Alternatively, they can be used as standard contrast
agents used for disease detection and characterization (e.g.,
[16]).
Inconclusion,consideringthecurrenttendsinradiology,
itcanbeexpectedthatMMIdeviceswillbecomeincreasingly
available in the clinical arena. PET/CT has already made an
important clinical contribution to patient care for oncology,
while the new combined SPECT/CT designs are enhancing
SPECT applications and improving physicians’ conﬁdence
with image interpretation. No doubt, new combinations of
hybrid devices will appear in the clinical arena and in many
situations.AsdemonstratedbyPET/CTintheoncologyﬁeld,
they will become the primary imaging option. A PET/MR
design for simultaneous acquisition of PET and MR has re-
cently acquired the ﬁrst patient images, and a combined PET
and ultrasound device is also under development for breast
imaging. For many reasons, therefore, hybrid imaging de-
vices are ﬁnding widespread acceptance within the clinical
environment and some are already contributing to patient
care and management. There is little doubt that this trend
will continue in the future with an increasing reliance on
MMI devices for medical imaging, thereby ensuring that all
involved can be satisﬁed that they will eventually obtain a
true and consistent picture of the elephant.
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